Novo Nordisk is chopping prices again for its popular obesity treatment Wegovy, but doctors say the expense will remain ...
Novo Nordisk cuts obesity drug prices to compete with Eli Lilly, offering new patient deals and nationwide access.
Eli Lilly and Novo Nordisk May Soon Sell Weight Loss Drugs on the Planned TrumpRx. Could This Further Boost the Healthcare Giants' Stocks? Investors will be watching what Trump makes happen.
Shares of Mangoceuticals surged 28% to $2.25 in premarket trading. U.S. regulations allow compounding pharmacies to copy ...
Shares in Novo Nordisk fell as much as 3 per cent on Friday after the Danish drugmaker and U.S. rival Eli Lilly agreed with ...
Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter. Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox. The news comes as ...
Eli Lilly's tirzepatide acts on two hormonal pathways, so it's called a dual GIP/GLP-1 receptor agonist, and it entered the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback